Literature DB >> 11455470

Prevention of severe change in acute pancreatitis: prediction and prevention.

H G Beger1, B Rau, R Isenmann.   

Abstract

Bacterial infection of pancreatic necrosis is the most frequent local complication of severe acute pancreatitis and is responsible for the majority of deaths in this disease. The development of systemic complications of severe acute pancreatitis such as septic multiple organ failure is closely related to infected necrosis. In this review, the factors predisposing to a severe course of acute pancreatitis are discussed as are clinical and laboratory markers which allow identification of patients at risk. Prevention of complications of acute pancreatitis is difficult. A variety of drugs including antiproteases and antiinflammatory agents have been shown to be of no benefit with regard to the reduction of severe complications. At present, based on the results of controlled trials, there is the widespread belief that prophylactic antibiotics are capable of reducing the incidence of infected pancreatic necrosis. New approaches for the prevention of systemic complications of severe acute pancreatitis are total enteral nutrition and local arterial infusion of antibiotics and antiproteases into the celiac trunk.

Entities:  

Mesh:

Year:  2001        PMID: 11455470     DOI: 10.1007/s005340170037

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  9 in total

Review 1.  Bio-ecological control of perioperative and ITU morbidity.

Authors:  Stig Bengmark
Journal:  Langenbecks Arch Surg       Date:  2003-11-07       Impact factor: 3.445

2.  Role of bedside pancreatic scores and C-reactive protein in predicting pancreatic fluid collections and necrosis.

Authors:  Doraiswami Babu Vinish; Vishnu Abishek; K Sujatha; S Arulprakash; Rajkumar Solomon; P Ganesh
Journal:  Indian J Gastroenterol       Date:  2017-02-09

3.  Planned staged reoperative necrosectomy using an abdominal zipper in the treatment of necrotizing pancreatitis.

Authors:  Dejan V Radenkovic; Djordje D Bajec; Gregory G Tsiotos; Aleksandar R Karamarkovic; Natasa M Milic; Branislav D Stefanovic; Vesna Bumbasirevic; Palve M Gregoric; Dragan Masulovic; Miroslav M Milicevic
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Factors predisposing to severe acute pancreatitis: evaluation and prevention.

Authors:  Bei Sun; Ha-Li Li; Yue Gao; Jun Xu; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

5.  Dexamethasone and dextran 40 treatment of 32 patients with severe acute pancreatitis.

Authors:  Zi-Fa Wang; Chang Liu; Yi Lu; Rui Dong; Jun Xu; Liang Yu; Ying-Min Yao; Qing-Guang Liu; Cheng-En Pan
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

6.  Changes of cytosolic [Ca2+]i in neutrophils in pancreatic microcirculation of rats with caerulein-induced acute pancreatitis under fluid shear stress.

Authors:  Zong-Guang Zhou; You-Qin Chen; Xu-Bao Liu; Wei-Ming Hu; Bo-Le Tian; Huai-Qing Chen
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

Review 7.  Acute pancreatitis: risk of recurrence and late consequences of the disease.

Authors:  Juhani Sand; Isto Nordback
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07-07       Impact factor: 46.802

8.  Epidural anesthesia improves pancreatic perfusion and decreases the severity of acute pancreatitis.

Authors:  Samira M Sadowski; Axel Andres; Philippe Morel; Eduardo Schiffer; Jean-Louis Frossard; Alexandra Platon; Pierre-Alexandre Poletti; Leo Bühler
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

9.  Epidural anaesthesia restores pancreatic microcirculation and decreases the severity of acute pancreatitis.

Authors:  Alp Demirag; Catherine M Pastor; Philippe Morel; Copin Jean-Christophe; Andreas W Sielenkämper; Nilgun Güvener; Gang Mai; Thierry Berney; Jean-Louis Frossard; Leo H Bühler
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.